Fate Therapeutics (FATE) Shares Outstanding (Entity) (2012 - 2026)
Powered by 
Analysis
Fate Therapeutics (FATE) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Fate Therapeutics | 297.38 Mn | 297.38 Mn | - | 116.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116.69 Mn |
| Mar 31, 2026 | 116.27 Mn |
| Dec 31, 2025 | 115.36 Mn |
| Sep 30, 2025 | 115.34 Mn |
| Jun 30, 2025 | 114.66 Mn |
| Mar 31, 2025 | 114.60 Mn |
| Dec 31, 2024 | 113.93 Mn |
| Sep 30, 2024 | 113.88 Mn |
| Jun 30, 2024 | 113.85 Mn |
| Mar 31, 2024 | 113.80 Mn |
| Dec 31, 2023 | 98.63 Mn |
| Sep 30, 2023 | 98.59 Mn |
| Jun 30, 2023 | 98.52 Mn |
| Mar 31, 2023 | 98.19 Mn |
| Dec 31, 2022 | 97.29 Mn |
| Sep 30, 2022 | 97.11 Mn |
| Jun 30, 2022 | 96.86 Mn |
| Mar 31, 2022 | 96.54 Mn |
| Dec 31, 2021 | 95.73 Mn |
| Sep 30, 2021 | 95.36 Mn |